Articles

CLINICAL USE AND PHARMACOLOGICAL PROPERTIES OF ADVANTAN® (0.1% METHYLPREDNISOLONE ACEPONATE) OINTMENT

Vol. 5 No. 8 (2025): Eurasian Journal of Academic Research 74-76

2025-08-31 Articles CC BY 4.0 Open Access

Authors

  • Umida Kocherova Alfraganus Universiteti Tibbiyot fakulteti farmasevtika yo'nalishi 2-kurs talabasi

Abstract

This article discusses the clinical application and pharmacological properties of Advantan® (0.1% methylprednisolone aceponate) ointment in dermatological diseases. As a topical glucocorticosteroid, it exhibits anti-inflammatory, antiallergic, and immunosuppressive effects. Advantan is effective in atopic dermatitis, eczema, contact dermatitis, and allergic dermatoses. Clinical studies have demonstrated its high efficacy and relative safety. When applied topically, systemic absorption is minimal, ensuring good outcomes in both children and adults during short-term treatment. The article also highlights administration methods, dosage, contraindications, and safety considerations.

Keywords:

References

Abdullayev A.A., Karimov B.X. Dermatovenerologiya. – Toshkent: Tibbiyot nashriyoti, 2018.

Rahmatullayev R.R. Farmakologiya: Darslik. – Toshkent: Tibbiyot nashriyoti, 2019.

Jo‘rayev Sh.M. Bolalar dermatologiyasi asoslari. – Toshkent: Ilm-Ziyo, 2020.

Xolmatova D.S. Teri kasalliklari va ularning davolash usullari. – Samarqand: SamDU nashriyoti, 2021.

O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. Dermatologik kasalliklarni davolash bo‘yicha klinik protokollar. – Toshkent: SSV, 2022.

Rustamov O.T. Farmatsevtik ensiklopediya. – Toshkent: O‘zbekiston milliy ensiklopediyasi, 2017.

Readership

2 Views
0 PDF downloads
2 Countries

    Published

    2025-08-31

    How to Cite

    Kocherova , U. . (2025). CLINICAL USE AND PHARMACOLOGICAL PROPERTIES OF ADVANTAN® (0.1% METHYLPREDNISOLONE ACEPONATE) OINTMENT. Eurasian Journal of Academic Research, 5(8), 74-76. https://www.in-academy.uz/index.php/EJAR/article/view/6565
    Innovative Academy RSC
    Article metrics Views and PDF downloads
    0 Views
    0 Downloads